HIV incidence among injection drug users in Baltimore, Maryland (1988-2004)

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 3, 2006, Pages 368-372

  Mehta, Shruti H ^a   Galai, Noya ^a,b   Astemborski, Jacquie ^a   Celentano, David D ^a   Strathdee, Steffanie A ^a,c   Vlahov, David ^a,d   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF HAIFA   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

HIV AIDS; Incidence; Injection drug users

Indexed keywords

ADULT; ANTIBODY SCREENING; ARTICLE; DRUG ABUSE; DRUG INSTILLATION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL BEHAVIOR; UNITED STATES; VIRUS TRANSMISSION;

ADULT; BALTIMORE; COHORT STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33750535831     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000243050.27580.1a     Document Type: Article

References (26)

1. Fleming PL, Ward JW, Karon JM, et al. Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS. 1998;12(Suppl A):S55-S61.
2. Centers for Disease Control and Prevention. HIV and AIDS - United States, 1981-2000. MMWR Morb Mortal Wkly Rep. 2001;50:430-434.
3. Longshore D, Anglin MD. Seroprevalence stable and seroconversions rare among injection drug users in Los Angeles. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5:212-213.
4. Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7:1276-1281.
5. Des J, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352-359.
6. Des JC, Perlis T, Friedman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health. 2000;90:1112-1116.
7. Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidemiol. 2003;157:915-922.
8. Moss AR, Vranizan K, Gorter R, et al. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS. 1994;8:223-231.
9. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a 4-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:282-289.
10. Nelson KE, Galai N, Safaeian M, et al. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156:641-653.
11. Nash D, Bennani Y, Ramaswamy C, et al. Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassay, New York City, 2001. J Acquir Immune Defic Syndr. 2005;39:102-111.
12. Des J, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
13. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75-100.
14. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14:367-378.
15. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
16. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
17. Hope VD, Judd A, Hickman M, et al. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS. 2005;19:1207-1214.
18. Strang J, Sheridan J, Hunt C, et al. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales. Br J Gen Pract. 2005;55:444-451.
19. Stolte IG, Dukers NH, Geskus RB, et al. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS. 2004;18:303-309.
20. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
21. Tun W, Gange SJ, Vlahov D, et al. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004;38:1167-1174.
22. Tun W, Celentano DD, Vlahov D, et al. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS. 2003;17:1953-1962.
23. Celentano DD, Galai N, Sethi AK, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001;15:1707-1715.
24. Vlahov D, Safaien M, Lai S, et al. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS. 2001;15:2311-2316.
25. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224-236.
26. Henderson LA, Walker DH. Drug use in the metropolitan area: epidemiology and trends, 1998 through the first half of 2002. National Institute on Drug Abuse, Epidemiologic Trends in Drug Abuse 2004;2:21-35.